Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With Breakthrough Cancer Pain
Clinical trial NCT04713189 · UNKNOWN
Trial details
- NCT number
- NCT04713189
- Sponsor
- Lee's Pharmaceutical Limited
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-15
- Primary completion
- 2021-12-21
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.